DIA/PhRMA Workshop to Explore Dried Blood Spot Sampling Implementation and Advances

The Drug Information Association (DIA), in cooperation with PhRMA, will host a workshop on Dried Blood Spot Sampling in the Pharmaceutical Industry: Methodology, Implementation and Best Practices on December 8, 2009 in Washington, DC.

Horsham, PA, USA (Vocus/PRWEB ) November 13, 2009 -- The Drug Information Association (DIA), in cooperation with PhRMA, will host a workshop on Dried Blood Spot Sampling in the Pharmaceutical Industry: Methodology, Implementation and Best Practices on December 8, 2009 in Washington, DC.

Dried blood spot (DBS) sampling on specialty papers is a novel methodology in the area of pharmacokinetics and toxicokinetics that serves to replace conventional plasma analysis for pharmaceutical development. The most notable advantage of this technique is the reduced blood collection volume requirements and ease of sample manipulation.

This one-day workshop will feature three cross-functional parallel tracks in toxicology/safety assessment (and in vivo considerations), bioanalytical, and pharmacokinetics/clinical that will:

Increase your awareness around DBS sampling Share best practices for DBS use/implementation, sample collection, handling, and associated bioanalysis across three separate functional areas Highlight opportunities for this technology to improve animal welfare and contribute to the 3Rs – replace, reduce, refine Discuss case studies around technique and implementation Discuss potential cost savings in the clinic – sample collection and sample shipment Discuss future direction(s) of DBS sampling (metabolite ID, direct analysis, biopharmaceuticals, etc.)

Additional highlights include:

Podium presentations from industry leaders in DBS sampling techniques Poster presentations around best practices, implementation, and advances Networking opportunities across clinical pharmacokinetics, regulatory, bioanalysis, toxicology and other preclinical disciplines

Register for Dried Blood Spot Sampling Workshop.

About the Drug Information Association (DIA)
A non-profit, neutral, multidisciplinary, global, member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit www.diahome.org or call 215-442-6100.

Contact:

Joe Krasowski
DIA
+1-215-293-5812
Joe.Krasowski (at) diahome (dot) org

###

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl

---

See Also:

• All Conferencing Announces Launch of Phone Reminder Service
• Federal Court Appoints Girard Gibbs LLP Partner to Plaintiffs' Steering Committee in the Consolidated Yasmin and Yaz Lawsuits
• NinjaTax Offers Free Tax Consultations
• Making the Best Choice in Prostate Cancer Treatment Robotic Prostate Surgical Outcomes Mean Trade-Offs For Patients
• Hormone Therapy Victims Win Important Appeal

[Via Legal / Law]

• buy accutane without prescription
• cheap propecia - order generic propecia online
• prescription drugs without script